Fimbrion Therapeutics fimbrion.com


Fimbrion Therapeautics aims to discover, develop, and commercialize antimicrobial-sparing, first-in-class antivirulence drugs for the prevention and treatment of infectious diseases caused by bacteria, including anbitiotic-resistant strains.

Fimbrion Therapeautics aims to discover, develop, and commercialize antimicrobial-sparing, first-in-class antivirulence drugs for the prevention and treatment of infectious diseases caused by bacteria, including anbitiotic-resistant strains.

Company (Alive / Active)

Phone:

Fax:

20 S. Sarah Street

 Saint Louis, 63108
 Missouri, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Fimbrion Therapeutics $0M Dec 30, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Fimbrion Therapeutics Jobs

jobs by Indeed job search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Mannose-derived antagonists of fimh useful for treating disease Mar 23, 2017 Aug 11, 2020 Patent
C-glycoside compounds useful for treating disease Mar 11, 2017 Application